M&A / Deals Sun Pharma to acquire Innovcare Lifesciences for $28.7m Pharmaceutical TechnologySun Pharmaceutical Industries has agreed to purchase India-based Innovcare Lifesciences in a deal valued at approximately Rs2.71bn ($28.7m).Read full story pharminent June 22, 2026 (Last updated: June 22, 2026) Pharmaceutical Technology Sun Pharmaceutical Industries has agreed to purchase India-based Innovcare Lifesciences in a deal valued at approximately Rs2.71bn ($28.7m). Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: The first 14 days: How specialty programs set patients up for successNext: Post-marketing oncology studies: Enabling faster recruitment and lower costs Related Stories M&A / Deals J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout pharminent July 31, 2026 M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026 M&A / Deals Argenx signs agreement to buy Forte Biosciences for $2.2bn pharminent July 28, 2026
